Excitatory non-adrenergic-non-cholinergic neuropeptides: Key players in asthma

European Journal of Pharmacology

Volumn 405, Issue 1-3, 2000, Pages 113-129

  Kraneveld, Aletta D ^a   James, Deborah E ^b   De Vries, Annick ^a   Nijkamp, Frans P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Animal model; Asthma; excitatory; Human; NANC (non adrenergic non cholinergic) nerve; Neuropeptide

Indexed keywords

ENDORPHIN; NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OPIATE PEPTIDE; PEPTIDE; PEPTIDE HORMONE; RECEPTOR SUBTYPE; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL MODEL; ASTHMA; BIOSYNTHESIS; CHRONIC INFLAMMATION; CONFERENCE PAPER; EOSINOPHIL; EXCITATION; HUMAN; IMMUNITY; INTESTINE; LUNG; MACROPHAGE; MAST CELL; METABOLISM; NERVOUS SYSTEM; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; RESEARCH; SECRETION; SKIN;

ANIMAL; ASTHMA; AUTONOMIC NERVOUS SYSTEM; HUMAN; NEUROPEPTIDES; RECEPTORS, NEUROPEPTIDE; RESPIRATORY PHYSIOLOGY;

EID: 0034730572     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00546-X     Document Type: Conference Paper

References (250)

1. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids
2. Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors
3. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist
4. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough
5. Role of tachykinins as contractile agonists of human airways in asthma
6. C-fiber mechanical stimulus-response functions are different in inflammatory versus neuropathic hyperalgesia in the rat
7. Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma
8. Calcitonin gene-related peptide modulates Langerhans cell antigen-presenting function
9. A comparison of beta-adrenergic receptors and in vitro relaxant responses to isoproterenol in asthmatic airway smooth muscle
10. Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi
11. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases
12. Proinflammatory peptides in sensory nerves of airways
13. Neural control of human airways in health and disease
14. Asthma as an axon reflex
15. Neuropeptides in the respiratory tract: Part II
16. Neuropeptides in the respiratory tract: Part I
17. Modulation of neurotransmission in airways
18. Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes
19. The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist
20. The effect of human calcitonin gene-related peptide on eosinophil chemotaxis in the rat airway
21. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans
22. Nitric oxide as a neurotransmitter in human airways
23. GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors
24. Neuroendocrine regulation of mucosal immunity
25. Inhaled substance P induces activation of alveolar macrophages and increases airway responses in the guinea-pig
26. Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigs
27. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma
28. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma
29. Neurotrophins: a link between airway inflammation and airway smooth muscle contractility in asthma?
30. The role of neurotrophins in allergic bronchial asthma
31. Regulation of immunoglobulin production by nerve growth factor: comparison with anti-CD40
32. Macrophage dependence of peripheral sensory nerve regeneration: possible involvement of nerve growth factor
33. Modulation by protein kinase C of the enhanced responsiveness to tachykinins in ovalbumin-sensitized guinea pig alveolar macrophages
34. Airways hyperreactivity and cellular accumulation in a delayed-type hypersensitivity reaction in the mouse: modulation by capsaicin-sensitive nerves
35. Substance P enhances IL-2 expression in activated human T cells
36. Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma
37. Immunohistochemical localization of 5-HT2A receptors in peripheral sensory axons in rat glabrous skin
38. Autoradiographic visualization of beta-adrenoceptor subtypes in human lung
39. Distribution of calcitonin gene-related peptide receptors in the lung
40. Neuropeptide-mediated regulation of hapten-specific IgE responses in mice: I. Substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitro
41. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist
42. Substance P and stress-induced changes in macrophages
43. The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo
44. Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects in vivo
45. Effects of inhaled substance P on airway responsiveness to methacholine in asthmatic subjects in vivo
46. Interaction of neuropeptides with human mast cells
47. Pulmonary reflexes: neural mechanisms of pulmonary defense
48. Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor
49. Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells
50. Cationic protein-induced sensory nerve activation: role of substance P in airway hyperresponsiveness and plasma protein extravasation
51. Substance P is a potent inducer of TNF and IL-1 secretion by macrophages: a potential role for TNF in the pathogenesis of asthma
52. Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects
53. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects
54. Adenosine-induced bronchoconstriction in asthma: antagonism by inhaled theophylline
55. Ultrastructural studies on the neuromuscular control of human tracheal and bronchial muscle
56. Control of human airway smooth muscle: in vitro studies
57. In vitro responses of airways from an asthmatic patient
58. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs
59. Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins
60. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol
61. Adrenergic and non-adrenergic inhibitory nerves in mammalian airways
62. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
63. Tachykinin-mediated modulation of the primary antibody response in rats: evidence for mediation by an NK-2 receptor
64. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones
65. Immunoregulatory effect of substance P in human eosinophil migratory function
66. Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs
67. Tachykinin-independent effects of capsaicin on smooth muscle in human isolated bronchi
68. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor
69. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist
70. SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor
71. Molecular characterization of the human beta 3-adrenergic receptor
72. Autoradiographic localization of changes in pulmonary beta-adrenoceptors in an animal model of atopy
73. Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects
74. Inhibition of LPS-induced TNF-alpha production by calcitonin gene-related peptide (CGRP) in cultured mouse peritoneal macrophages
75. Correlation of vasoactive intestinal peptide and nitric oxide synthase with choline acetyltransferase in the airway innervation
76. Induction of tachykinin gene and peptide expression in guinea pig nodose primary afferent neurons by allergic airway inflammation
77. Virus-induced airway hyperresponsiveness in the guinea-pig: possible involvement of histamine and inflammatory cells
78. Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics
79. Release of nerve growth factor from human airway epithelial cells
80. Calcitonin gene-related peptide inhibits proliferation and antigen presentation by human peripheral blood mononuclear cells: effects on B7, interleukin 10, and interleukin 12
81. Tachykinin receptors and the airways
82. Effect of tachykinins in small human airways
83. Pharmacological profile of a high affinity dipeptide NK1 receptor antagonist, FK888
84. Bronchoconstrictor response to inhaled capsaicin in humans
85. Bradykinin-induced bronchoconstriction in humans: mode of action
86. Effect of sub-diaphragmatic vagotomy on gastric mucosal mast cell population in pylorus ligated rats
87. Effects of eosinophil products upon sensory C-fibre neurones in cell culture
88. Pharmacological properties of a potent and selective nonpeptide substance P antagonist
89. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells
90. Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist
91. Identification of presynaptic beta 2-adrenoceptors on the sympathetic nerve fibres of the human pulmonary artery
92. A study of 5-HT-receptors associated with afferent nerves located in normal and inflamed rat ankle joints
93. Nerve growth factor enhances survival and cytotoxic activity of human eosinophils
94. Effects of activated eosinophils cultured from human umbilical cord blood on guinea pig trachealis
95. Activation of macrophages by neuropeptides
96. Expression of calcitonin gene-related peptide by cultured rat alveolar type II cells
97. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-gamma in stimulating the production of nerve growth factor in fibroblasts
98. Distribution of two VIP-related peptides, helospectin and pituitary adenylate cyclase activating peptide (PACAP), in the human upper respiratory system
99. Ozone-induced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects
100. Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects
101. Differential regulation of mRNA encoding nerve growth factor and its receptor in rat sciatic nerve during development, degeneration, and regeneration: role of macrophages
102. Effect of a novel tachykinin NK-2-receptor antagonist, TAC-363, on bronchoconstriction and airway hyperresponsiveness in guinea pigs
103. Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation
104. Effects of nerve growth factor on rat peritoneal mast cells: survival promotion and immediate-early gene induction
105. Mucosal nerves in endobronchial biopsies in asthma and non-asthma
106. Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor
107. Endogenous sensory neuropeptide release enhances nonspecific airway responsiveness in guinea pigs [see comments]
108. Pharmacology of the effects of bradykinin, serotonin, and histamine on the release of calcitonin gene-related peptide from C-fiber terminals in the rat trachea
109. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist
110. Enhancement of phagocytosis by corticostatin I (CSI) in cultured mouse peritoneal macrophages
111. A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients
112. Histamine H3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers: a regulatory negative-feedback loop
113. Differential effects of two C-terminal peptides of substance P on human neutrophils
114. Mechanism for substance P-induced activation of human neutrophils and eosinophils
115. Picomolar doses of substance P trigger electrical responses in mast cells without degranulation
116. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects
117. The effect of nedocromil sodium on the bronchoconstrictor effect of neurokinin A in subjects with asthma
118. The role of sensory neuropeptides in the pathogenesis of bronchial asthma
119. Sensory neuropeptides and the human lower airways: present state and future directions
120. The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics
121. Nerve growth factor suppresses apoptosis of murine neutrophils
122. Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor
123. Stem cell factor and interleukin 4 increase responsiveness of mast cells to substance P
124. Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro
125. A role for capsaicin sensitive, tachykinin containing nerves in chronic coughing and sneezing but not in asthma: a hypothesis
126. Gene expression of histamine H1 receptor in guinea pig primary sensory neurons: a relationship between H1 receptor mRNA-expressing neurons and peptidergic neurons
127. Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor
128. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets
129. Rat alveolar macrophages express preprotachykinin gene-I mRNA-encoding tachykinins
130. Nerve growth factor specifically induces human IgG4 production
131. Stimulation of Ig production and growth of human lymphoblastoid B-cell lines by nerve growth factor
132. Neurotrophin induced second messenger responses in rat brain synaptosomes
133. Role for neurokinin-2 receptor in interleukin-5-induced airway hyperresponsiveness but not eosinophilia in guinea pigs
134. Mast cells contribute to the cellular accumulation and tracheal hyperreactivity associated with pulmonary delayed-type hypersensitivity (DTH) reaction in the mouse
135. Characterization of eosinophil cell activation by peptides: differential effects of substance P, melittin, and FMET-Leu-Phe
136. C-terminal substance P fragments elicit histamine release from a murine mast cell line
137. Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model
138. The sensory and sympathetic innervation of guinea-pig lung and trachea as studied by retrograde neuronal tracing and double-labelling immunohistochemistry
139. Capsaicin pretreatment of guinea pigs in vivo prevents ovalbumin-induced tracheal hyperreactivity in vitro
140. Potentiation by viral respiratory infection of ovalbumin-induced guinea-pig tracheal hyperresponsiveness: role for tachykinins
141. Damage of the airway epithelium and bronchial reactivity in patients with asthma
142. Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs
143. Nonadrenergic bronchodilator mechanisms in normal human subjects in vivo
144. The role of pirenzepine-sensitive (M1) muscarinic receptors in vagally mediated bronchoconstriction in humans
145. Pulmonary chemoreflex sensitivity is enhanced by prostaglandin E2 in anaesthetised rats
146. Mast cells synthesize, store, and release nerve growth factor
147. Nerve growth factor as a paradigm of other polypeptide growth factors
148. Nerve growth factor: from neurotrophin to neurokine
149. Neuropeptide content of lungs from asthmatic and nonasthmatic patients
150. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve
151. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons
152. Effect of neuropeptides on production of inflammatory cytokines by human monocytes
153. Effects and distribution of vagal capsaicin-sensitive substance P neurons with special reference to the trachea and lungs
154. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man
155. Lack of efficacy of 4 weeks treatment with the neurokinin receptor antagonist FK224 in mild to moderate asthma
156. Peptide-containing nerve fibers in human airways: distribution and coexistence pattern
157. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II
158. Tachykinin receptor antagonists and potential clinical applications at peripheral level
159. Tachykinin receptors and airway pathophysiology
160. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors
161. The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways
162. Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs
163. Leukotriene B4 decreases the mechanical and thermal thresholds of C-fiber nociceptors in the hairy skin of the rat
164. Occurrence and effects of multiple tachykinins; substance P, neurokinin A and neuropeptide K in human lower airways
165. Nerve growth factor promotes human hemopoietic colony growth and differentiation
166. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells
167. Capsaicin inhibits airway hyperresponsiveness but not lipoxygenase activity or eosinophilia after repeated aerosolized antigen in guinea pigs
168. Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat
169. Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways
170. Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80
171. Peptidergic pathway in human skin and rat peritoneal mast cell activation
172. Effects of FK224, a novel compound NK1 and NK2 receptor antagonist, on airway constriction and airway edema induced by neurokinins and sensory nerve stimulation in guinea pigs
173. Effect of substance P on the expression of an adhesion molecule ICAM-1 in human vascular endothelial cells
174. Substance p-induced cutaneous and bronchial reactions in children with bronchial asthma
175. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi
176. Evidence for functional tachykinin NK1 receptors on human isolated small bronchi
177. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma
178. Peptidergic innervation of rat lymphoid tissue and lung: relation to mast cells and sensitivity to capsaicin and immunization
179. Neuropeptides modulate human eosinophil chemotaxis
180. Allergen-induced airway hyperresponsiveness
181. Abnormal intraepithelial airway nerves in persistent unexplained cough?
182. Regulation of substance P release mediated via prejunctional histamine H3 receptors
183. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics
184. Synthesis and release of nerve growth factor by rat macrophages
185. Nerve growth factor induces plasma extravasation in rat skin
186. Nerve growth factor induces growth and differentiation of human B lymphocytes
187. Neurotrophins: signals between the nervous and immune systems
188. The role of calcitonin gene-related peptide (CGRP) in macrophages: the presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cells
189. Calcitonin gene-related peptide is localised to human airway nerves and potently constricts human airway smooth muscle
190. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production
191. Eosinophil granule proteins activate human heart mast cells
192. Neuronal differentiation factors/cytokines and synaptic plasticity
193. Specific stimulation of human T lymphocytes by substance P
194. Substance P recognition by a subset of human T lymphocytes
195. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor
196. Activation of capsaicin-sensitive sensory fibers modulates PAF-induced bronchial hyperresponsiveness in anesthetized guinea pigs
197. The substance P receptor on rat mast cells and in human skin
198. Lack of effect of calcitonin gene-related peptide and amylin on major markers of glucose metabolism in hepatocytes
199. Comparative airway response to inhaled bradykinin, kallidin, and [des-Arg9]bradykinin in normal and asthmatic subjects
200. Calcitonin gene-related peptide: multiple actions, multiple receptors
201. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways
202. Receptors and antagonists for substance P and related peptides
203. Nerve supply to the lungs
204. The innervation of the lung
205. In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist
206. Enhancement by parainfluenza 3 infection of contractile responses to substance P and capsaicin in airway smooth muscle from the guinea pig
207. Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways
208. The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways
209. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells
210. Role of tachykinin NK2-receptor activation in the allergen-induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea-pigs
211. Involvement of tachykinin NK1 receptor in the development of allergen-induced airway hyperreactivity and airway inflammation in conscious, unrestrained guinea pigs
212. Role of tachykinin NK1 and NK2 receptors in allergen-induced early and late asthmatic reactions, airway hyperresponsiveness, and airway inflammation in conscious, unrestrained guinea pigs
213. Does histamine stimulate trigeminal nasal afferents?
214. Further evidence that tachykinin-induced contraction of human isolated bronchus is mediated only by NK2-receptors
215. Lower threshold and greater bronchomotor responsiveness of asthmatic subjects to sulfur dioxide
216. In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airways obstruction
217. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats
218. Nerve growth factor is preformed in and activates human peripheral blood eosinophils
219. Sensory neuropeptides and airway function
220. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres
221. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa
222. Functional properties of murine macrophages promoted by nerve growth factor
223. Protective effect of drugs on bronchoconstriction induced by sulphur dioxide
224. Intracellular signaling pathway of substance P-induced superoxide production in human neutrophils
225. Neurotrophic factors
226. Tachykinins mediate the acute increase in airway responsiveness caused by toluene diisocyanate in guinea pigs
227. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes
228. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis
229. Nerve growth factor is an autocrine survival factor for memory B lymphocytes
230. Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide
231. Autonomic innervation of human airways: structure, function and and pathophysiology in asthma
232. TNF-α plays an important role in tracheal vascular hyperpermeability in a murine delayed-type hypersensitivity reaction
233. Role of interleukin-5 and substance P in development of airway hyperreactivity to histamine in guinea-pigs
234. The effect of the NK2 tachykinin receptor antagonist SR 48968 (saredutant) on neurokinin A-induced bronchoconstriction in asthmatics
235. Multinucleated rat alveolar macrophages express functional receptors for calcitonin
236. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation
237. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P
238. Substance P modulates the release of locally synthesized nerve growth factor from rat saphenous nerve neuroma
239. Muscarinic receptors in human airways
240. Sensory innervation of the lungs and airways
241. In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P
242. Mast cells: the neuroimmune connection
243. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain
244. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation
245. Activation of human neutrophils by tachykinins: effect on formyl-methionyl-leucyl-phenylalanine- and platelet-activating factor-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity
246. The C-terminal part of VIP is important for receptor binding and activation, as evidenced by chimeric constructs of VIP/secretin
247. Cytokine regulation of nerve growth factor-mediated cholinergic neurotrophic activity synthesized by astrocytes and fibroblasts
248. Muscarinic inhibitory autoreceptors in different generations of human airways
249. Endogenous substance P mediates cold water stress-induced increase in interleukin-6 secretion from peritoneal macrophages
250. Neuropeptides promote neutrophil adherence to endothelial cell monolayers